[1] 中华医学会皮肤性病学分会真菌学组, 中国医师协会皮肤科医师分会医学真菌亚专业委员会, 中西医结合学会皮肤性病专业委员会真菌学组. 孢子丝菌病诊疗指南[J]. 中华皮肤科杂志, 2016(49):459. [2] 宁光. 糖皮质激素类药物临床应用指导原则解读[C]. 全国药物性损害与安全用药学术会议暨内分泌代谢疾病用药安全与药源性内分泌代谢疾病防治专题研讨会. 2011. [3] Ursini F, Russo E, Leporini C, et al. Lymphocutaneous sporotrichosis during treatment with anti-TNF-alpha monotherapy[J]. Case Rep Rheumatol, 2015:614504. doi:10.1155/2015/614504. [4] Tochigi M, Ochiai T, Mekata C, et al. Sporotrichosis of the face by autoinoculation in a patient undergoing tacrolimus treatment[J]. J Dermatol, 2012, 39(9):796-798. [5] 钟良瑞, 李国艳, 张荣鑫, 等. 系统性红斑狼疮合并皮肤淋巴管型孢子丝菌病1例[J]. 实用皮肤病学杂志, 2011, 4(2):124-125. [6] 孙乐栋, 曾抗, 孙影,等. 系统性红斑狼疮并发孢子丝菌病8例临床分析[J]. 中国真菌学杂志, 2006, 1(5):279-280. [7] Lipstein-Kresch E, Isenberg H D, Singer C, et al. Disseminated Sporothrix schenckii infection with arthritis in a patient with acquired immunodeficiency syndrome[J]. J Rheumatol, 1985, 12(4):805-808. [8] US Food and Drug Administration. Guidance for Industry:"Drug interaction studies-study design, data analysis, and implications for dosing and labeling". http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf. [9] Moreira JAS, Freitas DFS, Lamas CC. The impact of sporotrichosis in HIV-infected patients:a systematic review[J]. Infection, 2015, 43(3):267-276. [10] Sharon VR, Kim J, Sudhakar S, et al. Disseminated cutaneous sporotrichosis[J]. Lancet Infect Dis, 2013, 13(1):95. [11] Atiyah P, Victor M, Shabir L, et al. A 27-year-old severely immunosuppressed female with misleading clinical features of disseminated cutaneous sporotrichosis[J]. Case Rep Dermatol Med. 2016:9403690.doi:10.1155/2016/9403690. [12] Lyra MR, Nascimento MLFO, Varon, AG, et al. Immune reconstitution inflammatory syndrome in HIV and, sporotrichosis coinfection:report of two cases and review of the, literature[J]. Rev Soc Bras Med Trop, 2014, 47(6):806-809. [13] Queiroz-Telles F, Buccheri R, Benard G. Sporotrichosis in immunocompromised hosts[J]. J Fungi (Basel), 2019, 5(1):8. |